To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Both transarterial radioembolization (TARE) and bland transarterial embolization (TAE) have been shown in single-institution studies to have a substantial radiologic response for a variety of liver tumors, including neuroendocrine metastases. However, randomized controlled trials have not yet been published comparing these modalities.